Clinical Trial Update: Effects of Bronchial Segmental Endotoxin Instillation in Humans [Phase 2]

View source ↗

Summary

This item provides an update on a Phase 2 trial investigating bronchial segmental endotoxin instillation in humans for acute lung inflammation, with enrollment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Inflammation

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Acute Lung Inflammation | Phase 2 | Status: ENROLLING_BY_INVITATION